Injectable Non-Animal Stabilized Hyaluronic Acid as a Skin Quality Booster: An Expert Panel Consensus

J Drugs Dermatol. 2018 Jan 1;17(1):83-88.

Abstract

Hyaluronic acid (HA) is used extensively in aesthetic medicine thanks to its documented role in skin rejuvenation. The specific applications of HA-based products are not always fully acknowledged due to a lack of consistent recommendations. In this paper, the authors have summarized available published data on the range of applications of non-animal stabilized hyaluronic acid (NASHA®) gel skin boosters (NSBs) in several anatomical areas and types of patient, as well as their own recommendations. Overall, the panel agreed that a standard initial protocol treatment of up to 3 sessions, followed by a maintenance schedule, would allow patients to improve and then preserve skin quality over time. Indeed, distinct effects are evident after the first session, but a progressive enhancement of skin texture is detectable for up to 12 months after repeat treatment at 4 to 6 month intervals. Moreover, the authors agreed that the NASHA gel, reaching the dermis, is able to reestablish a greater degree of hydration and stimulate collagen that, in turn, restores the volume and density of the skin. Thus, a strong consensus was reached that NSB procedures are minimally invasive, safe, and effective, and designed to improve skin texture and maintain skin quality. <p><em>J Drugs Dermatol. 2018;17(1):83-88.</em></p>.

Publication types

  • Consensus Development Conference
  • Review

MeSH terms

  • Consensus
  • Dermatologic Agents / administration & dosage
  • Dermatologic Agents / pharmacology*
  • Dermis / physiology*
  • Drug Administration Schedule
  • Face
  • Gels
  • Hand
  • Humans
  • Hyaluronic Acid / administration & dosage
  • Hyaluronic Acid / pharmacology*
  • Injections, Intradermal
  • Rejuvenation
  • Skin Aging*
  • Skin Physiological Phenomena / drug effects*

Substances

  • Dermatologic Agents
  • Gels
  • Hyaluronic Acid